M&A Reports
Life Sciences M&A Report: Half-Year 2025
The first half of 2025 saw a continued slowdown in global M&A activity across the life sciences sector, with deal value dropping sharply to just under USD 48 billion across 44 deals—down from the strong figures seen in early 2024. This marks the lowest deal volume and value since Q1 2023, highlighting ongoing caution among […]
14 Jul 2025
Read moreLife Sciences M&A Report 2024
The life sciences M&A landscape has undergone a dynamic evolution over the past decade, marked by periods of rapid growth and subsequent declines. The 2020 peak, driven by pandemic-fueled investments and strategic acquisitions, highlighted the industry’s responsiveness to global healthcare demands. Following this peak, a declining trend in both the value and number of M&A […]
26 Feb 2025
Read moreLife Sciences M&A Report: Half-Year 2024
The first half of 2024 has been an active year for M&A’s in the life sciences industry. The overall data reflects significant quarterly fluctuations in the total value and count of M&A deals within the life sciences sector from 2022 to mid-2024, highlighting shifting market priorities and potential external influences such as regulatory changes or […]
27 Nov 2024
Read more